DEF 14A: Nature's Sunshine Products, Inc. Files Definitive Proxy Statement for 2024 Annual Meeting

Nature's Sunshine Products, Inc. has released its definitive proxy statement, outlining proposals for the upcoming 2024 Annual Meeting of Shareholders, including the election of directors, executive compensation, and ratification of the company's accounting firm.

Summary

• Nature's Sunshine Products, Inc. has filed its definitive proxy statement for the 2024 Annual Meeting of Shareholders.
• The meeting will be held on May 1, 2024, at the company's headquarters in Lehi, Utah.
• Shareholders will vote on three proposals: the election of directors, an advisory resolution on executive compensation, and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm.
• The Board of Directors recommends voting for all director nominees, the advisory resolution on executive compensation, and the ratification of Deloitte & Touche LLP.
• In 2023, Nature's Sunshine achieved net sales of $445.3 million and net income of $16.4 million.
• Adjusted EBITDA for 2023 was $40.4 million.
• The company's total shareholder return (TSR) was 6.9% in 2023.
• The proxy statement also details corporate governance practices, director and executive compensation, and security ownership.
• The company's Board of Directors consists of eight members, with seven being independent.
• The proxy statement includes information on the compensation of named executive officers (NEOs), including base salary, annual cash incentives, and long-term equity incentive awards.
• The company's compensation program is designed to reward performance, align with shareholder value creation, and attract and retain talented executives.
• The proxy statement also includes information on related-party transactions, the audit committee report, and security ownership of certain beneficial owners and management.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook, highlighting growth in key markets and improved profitability. However, it also acknowledges some challenges, such as unfavorable foreign exchange impacts and directors falling out of compliance with stock ownership guidelines. The overall sentiment is moderately positive.

Positives

• The company achieved strong growth in key markets, with Asia up 8% and North America up 4.9% in 2023.
• Cost-saving and efficiency strategies yielded improved profitability over the prior year.
• The company's compensation program is designed to reward performance and align with shareholder value creation.
• The Board of Directors is comprised of highly experienced and talented individuals.
• The company has a robust corporate governance framework in place.
• The company's annual cash incentive payout for NEOs in 2023 was 160% of target due to exceeding corporate revenue and adjusted EBITDA targets.
• Shareholders approved the executive compensation program with a 94.3 percent favorable vote in 2023.

Negatives

• Some directors have fallen out of compliance with the stock ownership guidelines due to a recent increase in director grant values and a drop in stock price.
• The company experienced unfavorable foreign exchange impacts in 2023.
• The company experienced reductions in Latin America and Other markets (1.1%) business units.

Risks

• The company faces risks related to cybersecurity and technology, global supply chain, and compliance with applicable global laws and regulations.
• The company's ability to maintain a well-stocked pipeline of product that can be quickly delivered to customers is a key area of oversight.
• The company's compliance with applicable global laws and regulations relating to the company's business model and products is a key area of oversight.

Future Outlook

As we look to 2024, we continue to expand our digital initiatives and investments in key markets. Consistent with these objectives, we will continue to prioritize investments in digital, field activation, manufacturing efficiency, and brand-building to enhance the customer experience. As such, we look forward to driving more growth in 2024.

Management Comments

• I invite you to attend the 2024 Natures Sunshine Products, Inc. Annual Meeting of Shareholders.
• Whether or not you plan to attend the Annual Meeting, and regardless of the number of shares you hold, it is important that your shares be represented and voted.
• Thank you for your continued support of Natures Sunshine Products, Inc.

Industry Context

Nature's Sunshine operates in the competitive direct selling and consumer products industry. The company's performance is influenced by factors such as consumer trends, competition, and regulatory changes. The proxy statement provides insights into the company's strategies for navigating this environment and creating shareholder value.

Comparison to Industry Standards

• The peer group used for executive compensation benchmarking includes companies such as BellRing Brands, Lifetime Brands, Medifast, and USANA Health Sciences.
• These companies were selected based on objective industry classifications, annual revenue, and market capitalization.
• The company's executive compensation program is designed to be market-competitive and align with industry best practices.

Related Party Transactions

• Since the beginning of fiscal 2022, there have been no transactions, and there currently are no proposed transactions, in excess of the Threshold, between the Company (or one of our subsidiaries) and a related person in which the related person had or will have a direct or indirect material interest.

Stakeholder Impact

• The company's performance and governance practices have a direct impact on shareholders, employees, customers, and other stakeholders.
• The company's compensation program is designed to align the interests of executives with those of shareholders.
• The company's commitment to corporate governance and ethical conduct is intended to protect the interests of all stakeholders.

Next Steps

• Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting of Shareholders on May 1, 2024.
• The company will continue to focus on expanding its digital initiatives and investments in key markets in 2024.

Key Dates

Keywords

proxy statement, annual meeting, directors, executive compensation, corporate governance, Deloitte & Touche, shareholders, adjusted EBITDA, stock options, Nature's Sunshine